For professionals

Future Fertility Programme Oxford (FFPO) is part of Oxford University Hospitals NHS Foundation Trust and works in collaboration with the University of Oxford Nuffield Department of Women's and Reproductive Health.

Ovarian and testicular tissue, which is intended for transplantation (human application), must be cryopreserved in a tissue bank which holds a Human Tissue Authority (HTA) Human Application (HA) Sector licence.

The FFPO tissue cryopreservation service operates under the Oxford Cell and Tissue Biobank (OCTB), HTA license number 11106.

Ovarian and testicular tissue can be procured either in Oxford or under an OCTB third party agreement at another hospital, local to the patient. All tissue is cryopreserved at OCTB, Oxford.

Fertility risk

As part of standard care, fertility risks and fertility preservation treatment options should be discussed at the time of initial diagnosis, at times of change of treatment plan and in the after care setting.

NICE Guidelines

For further information about risks to fertility and potential fertility treatment options please visit:

The Children's Cancer and Leukaemia Oncofertility Guidelines - CCLG members only

British Fertility Society

ASRM Guidelines 2019 (pdf)

If you have a query about the gonadotoxic risk of the proposed treatment for any of your patients, please contact OCTB and they will arrange a discussion with the FFPO Lead Consultant if relevant.

Eligibility criteria

Eligibility criteria - Forms and documents

If you are not sure if a patient meets our criteria, please refer them to OCTB and the FFPO Lead Consultant will review the individual case and discuss as appropriate with the FFPO MDT .

To refer an eligible patient please fully complete the relevant OCTB referral form and email it to us.

Referral forms - Forms and documents

Email: FutureFertilityTrust@ouh.nhs.uk